title: What should drive the choice of allergen for immunotherapy in polysensitized patients?
authors: Giorgio
authors: G
authors: Ciprandi
authors: Cristoforo
authors: C
authors: Incorvaia
authors: Paola
authors: P
authors: Puccinelli
authors: Ilaria
authors: I
authors: Dell'Albani
authors: Franco
authors: F
authors: Frati
mesh_terms: D000485:Allergens / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003429:Cross Reactions; D003888:Desensitization, Immunologic; D003937:Diagnosis, Differential; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy*; D007114:Immunization; D057970:Inappropriate Prescribing / Q000517:prevention & control; D011058:Pollen / Q000009:adverse effects / Q000276:immunology
chemical_list: D000485:Allergens